Walleye Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-243,372
| Closed | -$7.16M | – | 2627 |
|
|
2024
Q3 | $7.16M | Buy |
243,372
+92,552
| +61% | +$2.72M | 0.01% | 343 |
|
|
2024
Q2 | $3.55M | Buy |
150,820
+39,342
| +35% | +$925K | 0.01% | 574 |
|
|
2024
Q1 | $4.23M | Buy |
+111,478
| New | +$4.23M | 0.01% | 494 |
|
|
2022
Q2 | – | Sell |
-5,424
| Closed | -$312K | – | 2653 |
|
|
2022
Q1 | $312K | Buy |
+5,424
| New | +$312K | 0.01% | 1251 |
|